Guangxi Yulin Pharmaceutical Group is one of the member companies of Kangchen Pharmaceutical Group (1681.HK). It was formerly Yulin Pharmaceutical Factory founded in 1956. It is a Chinese medicine pharmaceutical company with the main business of research, development, production and sales of Chinese patent medicines and natural medicines. enterprise. Yulin Pharmaceutical's business has expanded to the fields of traditional Chinese herbal medicine processing, Chinese herbal medicine planting and operation, medicinal hollow capsule manufacturing, and domestic and international trade. The company has always adhered to market-oriented and projects as a carrier, strengthened the joint between industry, academia and research, has good product research and development capabilities and a foundation for external technical cooperation, and has more than 360 professionals of various types. It is the earliest Guangxi establishes a district (provincial)-level technology. One of the center's enterprises. For a long time, Yulin Pharmaceutical has always adhered to the corporate mission of "inheriting the past and expanding new things, and helping the people with good medicines", creating health for mankind, creating benefits for shareholders, creating future for employees, and creating benefits for society. As a member of Kangchen Pharmaceutical Group, Yulin Pharmaceutical will continue to enrich and optimize product structure, strengthen quality control, innovate product research and development and marketing models, and cooperate with customers for win-win cooperation.

The company's main products include 9 dosage forms and 69 varieties, including Zhenggushui, Shiduqing Capsules, Jigucao Capsules, Yunxiang Jing, Yinpu Jiedu Tablets, Zhenhuang Capsules (Zhenhuang Pills), Sanqishenyao Capsules, etc. Zhenggushui is selected. "China's Geographical Indications Products Ceremony". The company's products are reliable, with accurate efficacy and high brand awareness. The company has strong comprehensive treatment and preparation capabilities of traditional Chinese medicine, including 1.85 billion capsules/year, 760 million tablets/year, and 760,000 liters of tinctures/year. It has a sound quality assurance system, passed the GMP certification of TGA Australia in 1996, and passed the review for eight consecutive times. In 2003, it passed the national GMP certification as a whole. The company's production and sales scale has reached more than 500 million yuan and its operations are stable. The company has the right to operate self-operated import and export, export 50 products, exported to more than 30 countries and regions, and earns nearly 3 million US dollars in annual exports.